BLACKBERRY is a Percutaneous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Allergy Laboratories, Inc.. The primary component is Blackberry.
| Product ID | 54575-353_dbe7bebd-e445-4e59-8302-e706b795fbde | 
| NDC | 54575-353 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | BLACKBERRY | 
| Generic Name | Blackberry | 
| Dosage Form | Injection, Solution | 
| Route of Administration | PERCUTANEOUS; SUBCUTANEOUS | 
| Marketing Start Date | 1972-08-29 | 
| Marketing Category | BLA / BLA | 
| Application Number | BLA102192 | 
| Labeler Name | Allergy Laboratories, Inc. | 
| Substance Name | BLACKBERRY | 
| Active Ingredient Strength | 1 g/20mL | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2018-12-31 | 
| Marketing Start Date | 1972-08-29 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | BLA | 
| Application Number | BLA102192 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 1972-08-29 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | BLA | 
| Application Number | BLA102192 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 1972-08-29 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | BLA | 
| Application Number | BLA102192 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 1972-08-29 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | BLA | 
| Application Number | BLA102192 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 1972-08-29 | 
| Inactivation Date | 2020-01-31 | 
| Ingredient | Strength | 
|---|---|
| BLACKBERRY | 1 g/20mL | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 36987-1298 | Blackberry | Blackberry | 
| 36987-1299 | Blackberry | Blackberry | 
| 36987-1300 | Blackberry | Blackberry | 
| 36987-1301 | Blackberry | Blackberry | 
| 49288-0054 | Blackberry | Blackberry | 
| 54575-353 | BLACKBERRY | blackberry |